Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
作者信息
Mailankody Sham, Matous Jeffrey V, Chhabra Saurabh, Liedtke Michaela, Sidana Surbhi, Oluwole Olalekan O, Malik Shahbaz, Nath Rajneesh, Anwer Faiz, Cruz Jose Carlos, Htut Myo, Karski Erin E, Lovelace Wade, Dillon Myles, Butz Eric, Ying Wendy, Balakumaran Arun, Kumar Shaji K
机构信息
Myeloma Service and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
出版信息
Nat Med. 2023 Dec;29(12):3271. doi: 10.1038/s41591-023-02306-7.
PMID:36932247
Abstract
摘要
Zotero 插件